Pip Care to Improve Surgical Patient Outcomes

NCT ID: NCT06661291

Last Updated: 2025-10-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-13

Study Completion Date

2028-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pip Care is developing a personalized, interactive surgical journey platform with a live health coach that works directly with health systems to optimize the perioperative care process. Our Health Insurance Portability and Accountability Act (HIPAA)-compliant platform, Pip, can be integrated into any electronic medical record (EMR), thus alleviating the administrative burden by making operational workflows more efficient. The PIP empowers patients and their families to be more involved in their care by breaking down a patient's healthcare plan into definable, easy-to-understand, and easy-to-complete tasks. Additionally, a health coach completes a health intake to create a personalized perioperative care plan, meets regularly with the patient to encourage goal accomplishment, and facilitates care coordination. This project has 2 phases; Phase I is to assess usability of the Pip Care platform in surgical patients, Phase II is a RCT (Randomized Controlled Trial) to assess surgical clinical outcomes while using Pip compared to standard of care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the United States (US), 48 million surgeries are performed annually, and despite medical and surgical advancements, postoperative complications are the third leading cause of death. Perioperative risk varies between patients based on their health and surgical procedure. Patients with intermediate or high perioperative risk experience extended hospital stays, higher readmission rates, and frequent adverse events, including death. The national burden for such cases costs $31.35 billion annually. As a result, the healthcare industry is prioritizing the advancement of perioperative care to reduce postoperative complications and improve patient outcomes. While clinical care teams provide clinical pathways for patients, patients find the perioperative journey complex and impersonal. Patients often don't have access to a tailored preparation plan and personal guidance, emotional support, and motivation despite the high level of perioperative care detail and the vulnerable status of patients. Therefore, there is an unmet need to provide patients with comprehensive perioperative care guidance and support with the enhanced human touch to reduce postoperative complications. Integrating clinical pathways prepared by interdisciplinary care teams and digital health platform offers opportunities to improve patient outcomes through improved prehabilitation and postoperative engagement.

PRELIMINARY DATA:

The first version of Pip included three pathways (nutrition, fitness, and smoking cessation). In a pilot study with the Center for Perioperative Center (CPC) at the University of Pittsburgh Medical Center (UPMC), implementation of Pip resulted in the reduction of the median length of stay (LOS) by one day. The same-day surgery cancellations were avoided 99.5 % of the time. Pip also received an aggregate patient satisfaction score of 4.8 out of 5 (vs. industry benchmarks of 3.8-4.3).

Pip Care partnered with the UPMC CPC to digitize and implement clinical pathways, created by perioperative experts at UPMC, into modular digital care contents. Pip Care, CPC, and surgical offices developed a workflow that was both operationally and clinically seamless. The Pip DHP was designed to replace the time-consuming clinic follow-ups and care coordination through the different phases of the perioperative process. In addition to Health Coach follow-up, patients were invited to not only receive notifications and report outcomes, but to explore a library of educational multimedia resources on disease processes and why optimization of said diseases is important prior to surgery. Pip also identified patients who were not engaging with the clinical team and offered further remediation to help prevent poor outcomes.

Pip Digital Platform Development. The Pip technology platform is powered by two connected components: (1) Back-end platform utilized by health coaches and (2) Front-end native digital mobile application utilized by patients. The front-end digital mobile application contains four key features, which are represented by separate pages within the digital application: (1) Pip My Plan, which displays when patients are assigned personalized care plans and tasks by their Health Coach, (2) Pip Appointments, which patients schedule and join weekly video or voice calls with the Health Coach, (3) Pip Messages patients have access to unlimited engagement with their Health Coach, and (4) a library of health system-approved education content, including articles and videos, to assist with their surgery preparation and recovery. Figure 4 summarizes the initial Pip care plans: 8 total care plans including 3 clinical pathways (smoking cessation, weight management, and nutrition). To make the application patient-centered and accessible to all with mobile technology while improving communication, language for the application (e.g., questions, answers, instructions), and other content within the application are presented at a maximum reading level of the eighth grade. Pip is designed to function on both iOS (Apple Inc, Cupertino, CA) and Android (Google Inc, Mountain View, CA) operating systems.

Case Matched Pilot Clinical Study. A pilot clinical study at UPMC recently demonstrated feasibility and improved outcomes in case matched patients. The investigators have developed and validated the feasibility of the Pip Care digital platform with Health Coach and digital protocols. This was a Quality Improvement approved descriptive, prospective feasibility study of patients scheduled for elective surgery, invited to enroll in Pip from 2.5-4 weeks preoperatively through 4 weeks postoperatively at UPMC between 11/2/2022 - 3/27/2023. Descriptive primary endpoints included patient satisfaction, patient engagement, Pip Health Coach evaluations, and other PROs. Secondary endpoints included length of stay (LOS), readmission rates, and emergency department utilization rates within 30 days. Mean age was 64 years.

High Engagement and Satisfaction Scores. Our primary outcomes focused on feasibility of deployment of the combined platform and the patient assessment of the experience. Out of 283 patients invited to Pip, 172 patients (61%) were enrolled compared to industry benchmarks between (5% and 30%). Of those enrolled, 143 (83%) had one or more Health Coach sessions. During the study, of the patients who had one or more Health Coach sessions, 138 (97%) proceeded to surgery, a 4-8% improvement compared to industry benchmarks (90-93%). After surgery, 97 (70%) patients engaged with Pip postoperatively, a 35-126% improvement compared to industry benchmarks (31-52%). Pip received a total of 95 patient satisfaction survey submissions. Patients reported an overall high satisfaction based on the satisfaction survey (average score 4.8 out of 5, n=95). Patients strongly agree that Health Coach helped them throughout the perioperative process based on Pip Health Coach evaluation (average score 4.97 out of 5, n=33). The average Net Promotor Score, a customer experience metric, was 9.7 out of 10.

LOS and Readmission. Stabilized inverse probability of treatment weighting (SIPTW) was created to reduce selection bias and balance the patient characteristics (i.e., age, procedures, and perioperative risk score) in Pip and non-Pip cohorts. A total of 128 patients in the Pip cohort were compared to 268 patients in the non-Pip cohort. Pip was significantly associated with a 24% reduction in postoperative LOS (mean 2.4 vs. 3.1 days; median 1.9 vs. 3.0 days; mean ratio: 0.76; 95%CI: 0.62-0.93). Pip was associated with a 49% lower risk in 7-day readmission (relative risk: 0.51; 95%CI: 0.11-2.31) and 17% lower risk in 30-day readmission (relative risk: 0.83; 95%CI: 0.30-2.31), though not statistically significant. Pip and non-Pip groups had similar risk in 30-day ED returns (relative risk: 1.06; 95%CI: 0.56-2.01).

Patient Feedback to the Health Coach. An overwhelmingly positive aspect was the patient feedback and response to the Health Coach. The following comments support current evidence that high level engagement is very important to patients and their outcomes

"This has been a medical experience I will not forget. \[The Health Coach\] was patient and kind and encouraging. His support was vital to my experience." - Patient

"Talking to \[the Health Coach\] has helped me to feel a bit better and know that I am doing all that is in control to get ready for surgery." - Patient

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A Randomized Clinical Trial to determine the effectiveness of Pip Care in improving clinical and patient reported outcomes when compared to standard perioperative care in 1300 subjects.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pip Care Intervention Group

Subjects randomized to the Pip Care Intervention group will receive access to the Pip Care digital health platform 1-week prior to their scheduled elective, inpatient surgery and retain access to the digital health platform for 30-days following surgery.

Group Type EXPERIMENTAL

Pip Care Digital Health Platform

Intervention Type OTHER

Pip Care Digital Health Platform is a smartphone application granting access to a health coach who will assist the patient in completing a health intake, creating personalized perioperative care plans, and meets regularly with the patient to encourage goal accomplishments and supports healthy surgical recovery.

Standard of Care Group

Subjects randomized to the standard of care group will receive routine standard of care for their planned elective, inpatient surgery.

Group Type ACTIVE_COMPARATOR

Standard of Care Protocol

Intervention Type OTHER

Subjects in this intervention group will receive routine, standard of care throughout their surgery and hospital stay as determined by their acting clinical care team.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pip Care Digital Health Platform

Pip Care Digital Health Platform is a smartphone application granting access to a health coach who will assist the patient in completing a health intake, creating personalized perioperative care plans, and meets regularly with the patient to encourage goal accomplishments and supports healthy surgical recovery.

Intervention Type OTHER

Standard of Care Protocol

Subjects in this intervention group will receive routine, standard of care throughout their surgery and hospital stay as determined by their acting clinical care team.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult patient ≥18 years old
2. Planned elective, inpatient surgery between 2 to 8 weeks following enrollment in Pip within the following surgical specialties: complex abdominal surgery (general surgery, colorectal surgery, surgical oncology), gynecologic oncology, thoracic surgery, spine surgery, and orthopedic joint surgery
3. Daily access to a smartphone or tablet.

Exclusion Criteria

1. Unable to speak English
2. Unable to use a smartphone or tablet independently or with daily assistance.
3. Currently pregnant (assessed via standard-of-care pre-operative workup)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

University of Pittsburgh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jennifer Holder-Murray

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer Holder-Murray, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh, UPMC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UPMC Jameson Hospital

New Castle, Pennsylvania, United States

Site Status RECRUITING

UPMC East Hospital

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

UPMC Horizon

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

UPMC Magee Womens Hospital

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

UPMC Presbyterian Hospital

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

UPMC St. Margaret

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

UPMC Shadyside Hospital

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

UPMC Passavant Hospital

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carly Riedmann, MPH

Role: CONTACT

412-623-4147

Amy Monroe, MPH, MBA

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jennifer Holder-Murray, MD

Role: primary

877-684-7189

Amy Monroe, MPH, MBA

Role: backup

412-623-6382

Jennifer Holder-Murray, MD

Role: primary

877-684-7189 ext. 877-684-7189

Amy Monroe, MPH, MBA

Role: backup

Jennifer Holder-Murray, MD

Role: primary

877-684-7189

Amy Monroe, MPH, MBA

Role: backup

Jennifer Holder-Murray, MD

Role: primary

877-684-7189

Amy Monroe, MPH, MBA

Role: backup

Jennifer Holder-Murray, MD

Role: primary

877-684-7189

Amy Monroe, MPH, MBA

Role: backup

Jennifer Holder-Murray, MD

Role: primary

877-684-7189

Amy Monroe, MPH, MBA

Role: backup

Jennifer Holder-Murray, MD

Role: primary

877-684-7189

Amy Monroe, MPH, MBA

Role: backup

Jennifer Holder-Murray, MD

Role: primary

877-684-7189

Amy Monroe, MPH, MBA

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R42HL174371

Identifier Type: NIH

Identifier Source: secondary_id

View Link

STUDY25010036

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

WATER IV Prostate Cancer
NCT06651632 RECRUITING NA
Physical Therapy for Men Undergoing Prostatectomy
NCT02558946 ACTIVE_NOT_RECRUITING NA